2 completed, 1 not yet recruiting, 1 unknown. 2 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Betahistine Mesylate tablet: new trials by email Literature Review of Betahistine Mesylate tablet trials Research Report on Betahistine Mesylate tablet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Rimegepant for Acute Dizziness Rimegepant 75mg Orally Disintegrating Tablets (ODT), Betahistine Mesylate tablet - Dizziness | Phase 2 / Phase 3 | Not yet recruiting | Shi Tianming | 370 | 2026-03-20 | 2026-02-27 |
| Comparing Oral Lumbrokinase DLBS1033 and Betahistine Mesylate in Benign Paroxysmal Positional Vertigo DLBS1033, Betahistine Mesylate tablet - Benign Paroxysmal Positional Vertigo (Disorder) | Phase 4 | Completed | Universitas Sebelas Maret | 44 | 2024-04-01 | 2025-07-20 |
| Laser Acupuncture for Meniere Disease Multiwave Locked System (MLS) laser (Mphi laser, ASA Srl, Vicenza, Italy), Betahistine Mesylate tablet - Meniere Disease | Phase 2 | Unknown | Beijing Tongren Hospital | 324 | 2021-05-01 | 2024-08-09 |
| Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease taVNS, Betahistine Mesylate tablet - Meniere Disease | Completed | Beijing Tongren Hospital | 77 | 2019-01-01 | 2024-08-09 |
Dizziness (2) · Meniere Disease (2) · Benign Paroxysmal Positional Vertigo (1) · Inflammation (1)
Beijing Tongren Hospital (2) · Shi Tianming (1) · Universitas Sebelas Maret (1)
China (2) · Indonesia (1)